CRF Connect Logo
  • Tracks & Learning Series
    VIEW ALL
  • Conferences
  • My Favorites

Coronary

Clinical Indications and Science Learning Series

Clinical Trials & Science

Advertisement

Coronary >
Clinical Trials & Science

Episodes

Beyond LDL

Beyond LDL

14 min.

Expanding Your Lane and Not Your Waist: Cardiologists and GLP1-RA/SGLT2i

Expanding Your Lane and Not Your Waist: Cardiologists and GLP1-RA/SGLT2i

12 min.

Lipoprotein(a): Why Measure and What to Do?

Lipoprotein(a): Why Measure and What to Do?

11 min.

Ongoing Trials in CTO PCI: Ischemia-CTO, Co-CTO, Invest-CTO, STAR

Ongoing Trials in CTO PCI: Ischemia-CTO, Co-CTO, Invest-CTO, STAR

16 min.

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

15 min.

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent  10-Year Results From the Randomized ISAR-DESIRE 3 Trial

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial

15 min.

Advances in Holographic Imaging for Procedural Planning and Guidance (Realview)

Advances in Holographic Imaging for Procedural Planning and Guidance (Realview)

12 min.

Optical Coherence Tomography-based Functional Stenosis Assessment: FUSION - A Prospective Multi-Center Trial

Optical Coherence Tomography-based Functional Stenosis Assessment: FUSION - A Prospective Multi-Center Trial

11 min.

An Optical Coherence Tomography Guided Non-Stenting Reperfusion Strategy in Patients with STEMI— A Prospective, Multi-Centre, Observational Study (EROSION II)

An Optical Coherence Tomography Guided Non-Stenting Reperfusion Strategy in Patients with STEMI— A Prospective, Multi-Centre, Observational Study (EROSION II)

14 min.

First-in-Man Intravascular Fluorescence Lifetime ImaGing for Highly-Sensitive Molecular Characterization of Coronary AtheromaTa (FLIGHT Trial)

First-in-Man Intravascular Fluorescence Lifetime ImaGing for Highly-Sensitive Molecular Characterization of Coronary AtheromaTa (FLIGHT Trial)

8 min.

SpectraWAVE - HyperVue Imaging System

SpectraWAVE - HyperVue Imaging System

11 min.

Measuring Blood Flow in Heart Vessels With a New Fibre Optic Sensor

Measuring Blood Flow in Heart Vessels With a New Fibre Optic Sensor

9 min.

Physiology to Optimize PCI: Lessons Learnt From Define-GPS

Physiology to Optimize PCI: Lessons Learnt From Define-GPS

11 min.

Long-term Clinical Outcomes After iFR vs. FFR Guided Coronary Revascularization – Insights From the SWEDEHEART National Registry

Long-term Clinical Outcomes After iFR vs. FFR Guided Coronary Revascularization – Insights From the SWEDEHEART National Registry

15 min.

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

24 min.

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

14 min.

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

18 min.

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial

15 min.

How I Have Started to Use DCB’s: A Look into the Future

How I Have Started to Use DCB’s: A Look into the Future

15 min.

AGENT-IDE Deeper Dive: Key Subgroups and Perspectives

AGENT-IDE Deeper Dive: Key Subgroups and Perspectives

19 min.

AGENT-IDE Data Dive: Background, Trial Design, and Primary Results

AGENT-IDE Data Dive: Background, Trial Design, and Primary Results

11 min.

Current Treatment of In-Stent Restenosis: What the Rest of the World Does

Current Treatment of In-Stent Restenosis: What the Rest of the World Does

13 min.

Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The Randomized PICSO-AMI-I Trial

Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The Randomized PICSO-AMI-I Trial

22 min.

Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial

Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial

18 min.

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

20 min.

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

9 min.

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

13 min.

We Need More Data Following REVIVED: Unanswered Questions, Current and Future Trials

We Need More Data Following REVIVED: Unanswered Questions, Current and Future Trials

12 min.

Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?

Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?

14 min.

Percutaneous Revascularization for Patients With Left Ventricular Dysfunction: REVIVED-BCIS2 – What Do We Know One Year On?

Percutaneous Revascularization for Patients With Left Ventricular Dysfunction: REVIVED-BCIS2 – What Do We Know One Year On?

13 min.

Ionir Ultrathin Polymer Mesh Coronary DES

Ionir Ultrathin Polymer Mesh Coronary DES

6 min.

Immediate and Follow-Up Outcomes of Drug-Coated Balloon Angioplasty in de Novo Long Lesions on Large Coronary Arteries

Immediate and Follow-Up Outcomes of Drug-Coated Balloon Angioplasty in de Novo Long Lesions on Large Coronary Arteries

8 min.

Drug-Coated Balloon Angioplasty For De Novo Lesions on Left Anterior Descending Artery

Drug-Coated Balloon Angioplasty For De Novo Lesions on Left Anterior Descending Artery

8 min.

Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: The DEBuT-LRP Study

Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: The DEBuT-LRP Study

10 min.

Twelve-Month Follow-Up Outcomes of a Prospective, Multi-Center, Open, Single-Arm Study of the First Everolimus-Coated Balloon for the Treatment of Coronary In-Stent Restenosis (CVT-ISR Study)

Twelve-Month Follow-Up Outcomes of a Prospective, Multi-Center, Open, Single-Arm Study of the First Everolimus-Coated Balloon for the Treatment of Coronary In-Stent Restenosis (CVT-ISR Study)

14 min.

Treatment of Coronary De-Novo Lesions by a Sirolimus or a Paclitaxel Coated Balloon in a European Population

Treatment of Coronary De-Novo Lesions by a Sirolimus or a Paclitaxel Coated Balloon in a European Population

14 min.

A Prospective, Multicenter, Randomized Trial Comparing Sirolimus-Coated Balloon with Paclitaxel-Coated Balloon in De-Novo Small Vessels: The TRANSFORM I Trial

A Prospective, Multicenter, Randomized Trial Comparing Sirolimus-Coated Balloon with Paclitaxel-Coated Balloon in De-Novo Small Vessels: The TRANSFORM I Trial

19 min.

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

13 min.

Unloading in AMI:  Changing the Paradigm from DTB to DTU

Unloading in AMI: Changing the Paradigm from DTB to DTU

9 min.

Debate: Revascularization in Chronic Heart Failure after REVIVED - Revascularize!

Debate: Revascularization in Chronic Heart Failure after REVIVED - Revascularize!

5 min.

Debate: Revascularization in Chronic Heart Failure after REVIVED - is GDMT enough?!

Debate: Revascularization in Chronic Heart Failure after REVIVED - is GDMT enough?!

4 min.

Latest Data From REVIVED

Latest Data From REVIVED

7 min.

How Do the Coronary Revascularization Clinical Trials Apply to the Patient in Front of Me?

How Do the Coronary Revascularization Clinical Trials Apply to the Patient in Front of Me?

12 min.

Novel Approaches to Reduce and Reverse Bleeding in Complex PCI

Novel Approaches to Reduce and Reverse Bleeding in Complex PCI

8 min.

Revascularization in LV Systolic Dysfunction: Revived or Dead?

Revascularization in LV Systolic Dysfunction: Revived or Dead?

12 min.

This website uses cookies to ensure you get the best experience on our website. Read More